-
WHAT DOES IT TAKE TO ATTAIN ASMR - I/II IN FRANCE: REVIEW OF HTA ASSESSMENTS IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF GLP-1/GIP THERAPY FOR OBESITY IN BULGARIA
Aug 11, 2026, 17:16 PM -
JOINT CLINICAL ASSESSMENT BEYOND REIMBURSEMENT: CROSS-FUNCTIONAL USE OF JCA EVIDENCE ACROSS MARKET ACCESS AND MEDICAL AFFAIRS
Aug 11, 2026, 17:16 PM -
ALCOHOL USE DISORDER (AUD) SCREENING FOLLOWS DIAGNOSIS RATHER THAN PRECEDING IT: EVIDENCE OF SYSTEMIC WORKFLOW GAPS FROM NORSTELLALINQ REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF THE UNPLUGGED PROGRAM: A COST-BENEFIT ANALYSIS OF A SCHOOL-BASED SUBSTANCE USE PREVENTION PROGRAM IN FRANCE
Aug 11, 2026, 17:16 PM -
CONTROLLING FOR WHAT COMES NEXT: ESTIMATING GENERALIZED DIRECT EFFECTS OF FIRST-LINE THERAPY ON REAL-WORLD OVERALL SURVIVAL USING COUNTERFACTUAL SECOND-LINE DISTRIBUTIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
MODELING THERAPEUTIC PERSISTENCE IN OCULAR THERAPIES: A REVIEW OF HTA SUBMISSIONS
Aug 11, 2026, 17:16 PM -
TEMPORAL TRENDS IN ICD-10-CM OBESITY CODING ACCURACY, 2021-2025: EVIDENCE FROM THE NORSTELLALINQ LINKED CLAIMS AND EHR DATABASE
Aug 11, 2026, 17:16 PM -
INVESTIGATING THE IMPACT OF HERPES ZOSTER ON QUALITY OF LIFE AND WORK PRODUCTIVITY AMONG PATIENTS IN SPAIN
Aug 11, 2026, 17:16 PM -
TREATMENT SEQUENCING AND LINE-OF-THERAPY PATTERNS IN THE BTKI ERA: REAL-WORLD EVIDENCE FROM 24,410 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS USING NORSTELLALINQ
Aug 11, 2026, 17:16 PM -
IMPACT OF THE MYCOCARE PATIENT SUPPORT PROGRAM ON THE MANAGEMENT OF PATIENTS WITH PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
Aug 11, 2026, 17:16 PM -
NEGOTIATED CLOSED BUDGETS AND GENERIC ENTRY IN ORAL ANTICOAGULANTS IN GREECE, 2021-2025: IMPROVING PATIENT ACCESS WHILE CONTAINING PHARMACEUTICAL EXPENDITURE
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPACT OF GENERIC SUBSTITUTION AND INSURANCE DRUG FORMULARY POLICIES ON MEDICATION COVERAGE DECISIONS AND PRESCRIBING IN SAUDI ARABIA PRIVATE HEALTHCARE SECTOR
Aug 11, 2026, 17:16 PM -
GENDER GAP IN MEDICINE AFFORDABILITY - NATIONWIDE EVIDENCE FROM FINLAND
Aug 11, 2026, 17:16 PM -
TARGETED SINGLE-RULE EXCLUSION SCREENERS FOR SYSTEMATIC AND TARGETED LITERATURE REVIEWS: SMALL LLMS REACH HIGH PRECISION ON RECURRING ELIGIBILITY CRITERIA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL BURDEN, HEALTHCARE RESOURCE UTILIZATION, AND SURVIVAL AMONG PATIENTS WITH ACUTE ISCHEMIC STROKE IN THE BRAZILIAN PRIVATE HEALTH SYSTEM: A REAL-WORLD RETROSPECTIVE COHORT
Aug 11, 2026, 17:16 PM -
SHIFTING THE COVID-19 VACCINE LANDSCAPE WITH LOWER REACTOGENICITY: BUDGET IMPACT OF NUVAXOVID IN UK OLDER ADULTS
Aug 11, 2026, 17:16 PM -
ANNUAL DIRECT MEDICAL COST OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES IN TURKIYE: A PUBLIC PAYER MICRO-COSTING ANALYSIS
Aug 11, 2026, 17:16 PM -
REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN ADVANCED/METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH AND WITHOUT ACTIONABLE GENOMIC ALTERATIONS: A POPULATION-BASED COHORT STUDY IN ENGLAND, 2017-2025
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATIONS OF NON-PHARMACOLOGIC MANAGEMENT FOR CONGESTIVE HEART FAILURE: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM
